Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2009 1
2010 1
2012 2
2014 2
2015 1
2016 1
2017 1
2018 1
2019 3
2020 1
2021 3
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
The Spliceosome: A New Therapeutic Target in Chronic Myeloid Leukaemia.
Lebecque B, Bourgne C, Munje C, Berger J, Tassin T, Cony-Makhoul P, Guerci-Bresler A, Johnson-Ansah H, Liu W, Saugues S, Tchirkov A, Vetrie D, Copland M, Berger MG. Lebecque B, et al. Among authors: berger j. Cancers (Basel). 2022 Sep 27;14(19):4695. doi: 10.3390/cancers14194695. Cancers (Basel). 2022. PMID: 36230624 Free PMC article.
Efficacy of ibrutinib in the treatment of Bing-Neel syndrome.
Cabannes-Hamy A, Lemal R, Goldwirt L, Poulain S, Amorim S, Pérignon R, Berger J, Brice P, De Kerviler E, Bay JO, Sauvageon H, Beldjord K, Mourah S, Tournilhac O, Thieblemont C. Cabannes-Hamy A, et al. Among authors: berger j. Am J Hematol. 2016 Mar;91(3):E17-9. doi: 10.1002/ajh.24279. Am J Hematol. 2016. PMID: 26689870 Free article. No abstract available.
A Proteomics-Based Analysis Reveals Predictive Biological Patterns in Fabry Disease.
Tebani A, Mauhin W, Abily-Donval L, Lesueur C, Berger MG, Nadjar Y, Berger J, Benveniste O, Lamari F, Laforêt P, Noel E, Marret S, Lidove O, Bekri S. Tebani A, et al. Among authors: berger j. J Clin Med. 2020 May 2;9(5):1325. doi: 10.3390/jcm9051325. J Clin Med. 2020. PMID: 32370284 Free PMC article.
Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34- and immature CD34+ cells.
Berger MG, Lebecque B, Tassin T, Dannus LT, Berger J, Soucal M, Guerci A, Cony-Makhoul P, Johnson H, Etienne G, Guyotat D, Gagnieu MC, Pereira B, Saugues S, Tournilhac O, Hermet E, Bourgne C. Berger MG, et al. Among authors: berger j. Sci Rep. 2021 Mar 17;11(1):6187. doi: 10.1038/s41598-021-85734-0. Sci Rep. 2021. PMID: 33731863 Free PMC article.
Measurement of imatinib uptake by flow cytometry.
Bourgne C, Bamdad M, Janel A, Libert F, Gagnieu MC, Rapatel C, Pigeon P, Pereira S, Hermet E, Guerci A, Pereira B, Makhoul PC, Ansah AJ, Cahn JY, Guyotat D, Trouillier S, Berger J, Boiret-Dupré N, Berger MG. Bourgne C, et al. Among authors: berger j. Cytometry A. 2012 Nov;81(11):996-1004. doi: 10.1002/cyto.a.22118. Epub 2012 Aug 28. Cytometry A. 2012. PMID: 22930640 Free article.
Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1.
Berger J, Vigan M, Pereira B, Nguyen TT, Froissart R, Belmatoug N, Dalbiès F, Masseau A, Rose C, Serratrice C, Pers YM, Bertchansky I, Camou F, Bengherbia M, Bourgne C, Caillaud C, Pettazzoni M, Berrahal A, Stirnemann J, Mentré F, Berger MG. Berger J, et al. Clin Pharmacokinet. 2019 Apr;58(4):469-482. doi: 10.1007/s40262-018-0708-8. Clin Pharmacokinet. 2019. PMID: 30128966 Clinical Trial.
Bone marrow hematons: An access point to the human hematopoietic niche.
Janel A, Berger J, Bourgne C, Lemal R, Boiret-Dupré N, Dubois-Galopin F, Déchelotte P, Bothorel C, Hermet E, Chabi S, Bay JO, Lambert C, Pereira B, Pflumio F, Haddad R, Berger MG. Janel A, et al. Among authors: berger j. Am J Hematol. 2017 Oct;92(10):1020-1031. doi: 10.1002/ajh.24830. Epub 2017 Jul 29. Am J Hematol. 2017. PMID: 28639326 Free article.
20 results